scholarly article | Q13442814 |
P50 | author | Analía Bortolozzi | Q61820544 |
P2093 | author name string | Andrea Ballabio | |
Miquel Vila | |||
Jordi Bové | |||
Albert Torra | |||
Annabelle Parent | |||
Thais Cuadros | |||
Esther Ruiz-Bronchal | |||
Beatriz Rodríguez-Galván | |||
P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
ZKSCAN3 is a master transcriptional repressor of autophagy | Q24319594 | ||
A gene network regulating lysosomal biogenesis and function | Q24339409 | ||
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade | Q24550950 | ||
Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo | Q24554527 | ||
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism | Q24603034 | ||
Structural Insights into the Functions of TBK1 in Innate Antimicrobial Immunity | Q27678533 | ||
eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation | Q27860920 | ||
TFEB at a glance | Q28074375 | ||
GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease | Q28083626 | ||
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action | Q28283418 | ||
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition | Q28301955 | ||
Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease | Q28569094 | ||
TFEB links autophagy to lysosomal biogenesis | Q29614835 | ||
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E | Q29618009 | ||
Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. | Q33690319 | ||
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult | Q33964044 | ||
Clinical progression in Parkinson disease and the neurobiology of axons. | Q34052764 | ||
Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases | Q34063565 | ||
Brain-derived neurotrophic factor enhances the expression of the monocarboxylate transporter 2 through translational activation in mouse cultured cortical neurons. | Q34170853 | ||
Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB | Q34342483 | ||
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy | Q34394233 | ||
α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons | Q34503671 | ||
New insights into the mechanism of action of amphetamines | Q34599276 | ||
TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation | Q34778203 | ||
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease | Q35157431 | ||
Transcriptional activation of lysosomal exocytosis promotes cellular clearance | Q35214694 | ||
Light-regulated translational control of circadian behavior by eIF4E phosphorylation | Q35655644 | ||
Role of extracellular signal regulated kinases 1 and 2 in neuronal survival | Q35778135 | ||
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers | Q36001179 | ||
eIF3 controls cell size independently of S6K1-activity | Q36414466 | ||
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. | Q36470315 | ||
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity | Q36835587 | ||
Cross-hemispheric dopamine projections have functional significance | Q37040687 | ||
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease | Q37043102 | ||
Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo | Q37319917 | ||
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism | Q37378754 | ||
Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. | Q37605158 | ||
Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond | Q37880904 | ||
Neurotoxin-based models of Parkinson's disease | Q37959729 | ||
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy. | Q38547455 | ||
Trophic factors for Parkinson's disease: To live or let die. | Q38697393 | ||
Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences | Q39639189 | ||
Pathogenic lysosomal depletion in Parkinson's disease | Q39655523 | ||
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys | Q40702469 | ||
Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. | Q40811557 | ||
Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. | Q40854118 | ||
Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage | Q40869105 | ||
BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1. | Q41546726 | ||
BAX channel activity mediates lysosomal disruption linked to Parkinson disease. | Q42364834 | ||
Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors | Q44357508 | ||
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth | Q46988918 | ||
Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. | Q48196753 | ||
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys | Q48197305 | ||
Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions | Q48581414 | ||
The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection | Q48774186 | ||
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. | Q48806014 | ||
The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells. | Q50952310 | ||
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. | Q51547401 | ||
Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways | Q83206154 | ||
Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer | Q84353474 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 6 | |
P921 | main subject | pleiotropy | Q1134884 |
neurodegeneration | Q1755122 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 1552-1567 | |
P577 | publication date | 2018-02-27 | |
P1433 | published in | Molecular Therapy | Q15762400 |
P1476 | title | Overexpression of TFEB Drives a Pleiotropic Neurotrophic Effect and Prevents Parkinson's Disease-Related Neurodegeneration | |
P478 | volume | 26 |
Q89880339 | A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro |
Q92139366 | A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models |
Q92523995 | Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30/TFEB transcriptional response |
Q64776622 | Emerging therapies in Parkinson disease - repurposed drugs and new approaches |
Q93064841 | Lysosomes as a therapeutic target |
Q93101629 | Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease |
Q57165218 | Selective autophagy as a potential therapeutic target for neurodegenerative disorders |
Q90073258 | Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts |
Q92756625 | Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies |
Search more.